Impact Factor
4.38
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
7.43
1,758 total citations
h5-index
65
h5 depth signal
Cited share
87.0%
215 of 247
Total citations
1,758
Citation footprint
Metric signal
8.00
External metric anchor
Self-citation
6.3%
111 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
292
Germany
188
Italy
81
Spain
78
Switzerland
70
Citing Fields of Research
Neuromuscular Disorders
1,149
Nervous System Disorders
179
Immunology
140
Neurodegenerative Disorders
134
Auto-Inflammatory Disorders
116
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,709
Articles tracked across the journal lifetime
Indexed publication set
247
215 cited publications
Last 12 months
153
25.5 publications/month
Open access share
81.0%
124 OA publications in the last year
Leading citing country
United States
292 citing publications
Leading citing field
Neuromuscular Disorders
1,149 citing publications
Latest tracked publication
1 November 2026
10 recent records available
Coverage & Indexing History
v6n1, Jan. 2019-
v1n1, 2014-
Active Coverage
Research Focus & Classification
Indexed Subjects
Neuromuscular Disorders
Issuing & Sponsoring Bodies
issuing body
American Academy of Neurology
Broad Categories
Neurology
Neuromuscular Disorders
MeSH Descriptors
Neurogenic Inflammation
Neuroimmunomodulation
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1212/nxi.0000000000200669
Open DOI
Functional and Structural Imaging Features of Cognitive Profiles in Multiple Sclerosis
Background and ObjectivesCognitive impairment affects 40%–70% of patients with multiple sclerosis (MS). Although recent hypothesis-driven and data-driven efforts have identified cognitive phenotype...
02
DOI 10.1212/nxi.0000000000200667
Open DOI
A 35-Year-Old Woman With Multiple Sclerosis and a New Atypical Thalamic Lesion
03
DOI 10.1212/nxi.0000000000200663
Open DOI
Serum Glial-Related Biomarkers Show Distinct Contributions to Radiologic and Clinical Outcomes in Early Multiple Sclerosis
04
DOI 10.1212/nxi.0000000000200673
Open DOI
MOG Antibody in Pregnancy and Breast Milk
05
06
DOI 10.1212/nxi.0000000000200652
Open DOI
Detection of MOG-IgG and MOG-IgA in Maternal Breast Milk and Infant Blood in MOGAD
07
DOI 10.1212/nxi.0000000000200675
Open DOI
MRI-Negative Sarcoid Myelitis Revealed by Spinal 18 F-FDG-PET Hypermetabolism
08
DOI 10.1212/nxi.0000000000200661
Open DOI
Astrocytic and Axonal Injury Biomarkers in AQP4 Antibody–Positive NMOSD
09
DOI 10.1212/nxi.0000000000200658
Open DOI
Evaluating the Clinical Utility of TSPO-PET in MS and the Influence of Methodological Heterogeneity
Background and ObjectivesPET imaging targeting the 18-kDa translocator protein (TSPO) is a widely used method to detect neuroinflammation in vivo and shows promise for detecting innate inflammatory...
10
DOI 10.1212/nxi.0000000000200653
Open DOI
Autologous Hematopoietic Transplantation Reduces Brain Inflammatory and Axoglial Damage Biomarkers in Multiple Sclerosis
Autologous hematopoietic stem cell transplantation (AHSCT) can induce long-lasting immune tolerance and disease quiescence in patients with severe multiple sclerosis (MS), but the underlying mechanisms are not well understood. We hypothe...